Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjoern Titz

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of Proteomics|June 9, 2016
Quantitative proteomics analysis using 2D-PAGE to investigate the effects of cigarette smoke and aerosol of a prototypic modified risk tobacco product on the lung proteome in C57BL/6 miceAshraf Elamin, Bjoern Titz, Sophie Dijon, et al.
Regulatory Toxicology and Pharmacology : RTP|November 8, 2016
Evaluation of the Tobacco Heating System 2.2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smokeAlberto Oviedo, Stefan Lebrun, Ulrike Kogel, et al.
Cell Discovery|September 21, 2016
JUN dependency in distinct early and late BRAF inhibition adaptation states of melanomaBjoern Titz, Anastasia Lomova, Allison Le, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 12, 2020
Respiratory Effects of Exposure to Aerosol From the Candidate Modified-Risk Tobacco Product THS 2.2 in an 18-Month Systems Toxicology Study With A/J MiceBjoern Titz, Alain Sewer, Karsta Luettich, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|April 15, 2018
A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1.2) compared with cigarette smoke. I. Inhalation exposure, clinical pathology and histopathologyBlaine W Phillips, Walter K Schlage, Bjoern Titz, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|April 7, 2015
A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco productBlaine Phillips, Emilija Veljkovic, Michael J Peck, et al.
Ophthalmology Science|April 30, 2026
Aqueous Humor Biomarkers, Efficacy, and Safety in Patients with Naïve Diabetic Macular Edema Treated with Faricimab: The ALTIMETER StudyPatricio G Schlottmann, Amani A Fawzi, Manuel Amador, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 6, 2018
Assessment of the impact of aerosol from a potential modified risk tobacco product compared with cigarette smoke on human organotypic oral epithelial cultures under different exposure regimensFilippo Zanetti, Alain Sewer, Elena Scotti, et al.
Toxicology Reports|September 30, 2020
Comparing the preclinical risk profile of inhalable candidate and potential candidate modified risk tobacco products: A bridging use caseWalter K Schlage, Bjoern Titz, Anita Iskandar, et al.
Journal of Applied Toxicology : JAT|April 7, 2021
Impact of whole-body versus nose-only inhalation exposure systems on systemic, respiratory, and cardiovascular endpoints in a 2-month cigarette smoke exposure study in the ApoE<sup>-/-</sup> mouse modelUlrike Kogel, Ee Tsin Wong, Justyna Szostak, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Proteomics|June 9, 2016
Quantitative proteomics analysis using 2D-PAGE to investigate the effects of cigarette smoke and aerosol of a prototypic modified risk tobacco product on the lung proteome in C57BL/6 miceAshraf Elamin, Bjoern Titz, Sophie Dijon, et al.
Regulatory Toxicology and Pharmacology : RTP|November 8, 2016
Evaluation of the Tobacco Heating System 2.2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smokeAlberto Oviedo, Stefan Lebrun, Ulrike Kogel, et al.
Cell Discovery|September 21, 2016
JUN dependency in distinct early and late BRAF inhibition adaptation states of melanomaBjoern Titz, Anastasia Lomova, Allison Le, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 12, 2020
Respiratory Effects of Exposure to Aerosol From the Candidate Modified-Risk Tobacco Product THS 2.2 in an 18-Month Systems Toxicology Study With A/J MiceBjoern Titz, Alain Sewer, Karsta Luettich, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|April 15, 2018
A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1.2) compared with cigarette smoke. I. Inhalation exposure, clinical pathology and histopathologyBlaine W Phillips, Walter K Schlage, Bjoern Titz, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|April 7, 2015
A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco productBlaine Phillips, Emilija Veljkovic, Michael J Peck, et al.
Ophthalmology Science|April 30, 2026
Aqueous Humor Biomarkers, Efficacy, and Safety in Patients with Naïve Diabetic Macular Edema Treated with Faricimab: The ALTIMETER StudyPatricio G Schlottmann, Amani A Fawzi, Manuel Amador, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 6, 2018
Assessment of the impact of aerosol from a potential modified risk tobacco product compared with cigarette smoke on human organotypic oral epithelial cultures under different exposure regimensFilippo Zanetti, Alain Sewer, Elena Scotti, et al.
Toxicology Reports|September 30, 2020
Comparing the preclinical risk profile of inhalable candidate and potential candidate modified risk tobacco products: A bridging use caseWalter K Schlage, Bjoern Titz, Anita Iskandar, et al.
Journal of Applied Toxicology : JAT|April 7, 2021
Impact of whole-body versus nose-only inhalation exposure systems on systemic, respiratory, and cardiovascular endpoints in a 2-month cigarette smoke exposure study in the ApoE<sup>-/-</sup> mouse modelUlrike Kogel, Ee Tsin Wong, Justyna Szostak, et al.
Pageof 5